Nature BiotechnologyVerified account

@NatureBiotech

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. Part of and .

NY/London/SF/LA/Heidelberg
Joined June 2009
Born March 1, 1996

Tweets

You blocked @NatureBiotech

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @NatureBiotech

  1. Microbiome studies in rodents that have linked human diseases to microbiomes questioned: Derek Lowe commentary on a recent Cell paper tells us we need much more rigorous evidence

    Undo
  2. As Brexit begins, we take a look at how 2020 negotiations could shake out for science.

    Undo
  3. Join experts in bioengineering exploring technologies with the potential to transform biomedical discovery and new medical solutions at our upcoming in Munich, Germany.

    Undo
  4. Gene expression is precisely modulated with CRISPR interference and mismatched guide RNAs in a paper.

    Undo
  5. Jan 23

    Among US startups, there are a lot of zombies out there. A new study in looks at Top-50 patent producing schools & finds 40% of the most recently formed university-licensed startups exist on paper but aren't truly operating.

    Data showing success/failure of university-licensed startups
    Undo
  6. . & reply to ‘Assessing the impact of generative AI on medicinal chemistry’

    Show this thread
    Undo
  7. Assessing the impact of generative AI on medicinal chemistry

    Show this thread
    Undo
  8. BIO releases the most comprehensive study to date on diversity in the biotech industry, one of the first to go beyond gender and collect data on the representation of people of color in the industry

    Undo
  9. We’re committed to supporting the global response to the by enabling access to the latest available research, evidence, and data on our dedicated page. All content is free and will continually be updated.

    Undo
  10. Experts in bioengineering exploring how to transform biomedical discovery will be at . Submit an abstract or register today for this unmissable event

    Undo
  11. Show this thread
    Undo
  12. Harvard chemist Charles Lieber lied about his alleged ties to Chinese researchers who paid him hundreds of thousands of dollars, according to federal prosecutors

    Undo
  13. Biotechnology's link to the walking dead?

    Undo
  14. The n-Lorem Foundation intends to form the connective tissue between patients, researchers, facilities and regulators needed to supply individual patients with RNA therapies designed to treat their own ultra-rare disease—at no cost

    Undo
  15. Combining cultivation with metagenomics AKA culture-enabled metagenomics improves our understanding of sparse microbiomes in human cystic fibrosis sputum samples, and could prove broadly applicable

    Undo
  16. Applications are now open for The Spinoff Prize, a new award for early stage university spinoff companies from around the world. The Spinoff Prize has been established by Nature Research in partnership with Merck.

    Undo
  17. The Blavatnik Life Science Fellowship at Yale seeks to engage young professionals with advanced training in the life sciences and business

    Undo
  18. Show this thread
    Undo
  19. CAR-T cells for solid tumors: there's a new target, Claudin-6. And combination with an RNA vaccine delivering Claudin-6 to immune cells boosts their function in mouse models of cancer

    Undo
  20. Resource: quantitative proteomics of 375 cell lines in the Cancer Cell Line Encyclopedia

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·